Study compares TTE with and without contrast in critically ill patients

12/22/2013 | Healio (free registration)

The mortality rate after transthoracic echocardiography with a perflutren-based ultrasound contrast agent was 28% lower than with noncontrast echocardiography at 48 hours in critically ill patients in a study reported in the journal Cardiovascular Imaging. "These results are reassuring, given previous reports suggesting an association between ultrasound contrast agents and increased mortality in critically ill patients," wrote researchers.

View Full Article in:

Healio (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC